Global Top Stock Picks from Analysts

1414 Degrees

Market Cap: AU$7.6m

Engages in developing and commercializing silicon-based thermal storage technology.

CNS Pharmaceuticals

Market Cap: US$4.9m

A clinical pharmaceutical company, develops anti-cancer drug candidates for the treatment of brain and central nervous system (CNS) tumors.

60 Degrees Pharmaceuticals

Market Cap: US$4.9m

A specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States.

GRI Bio

Market Cap: US$4.9m

A clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States.

Galecto

Market Cap: US$4.8m

A clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases.

Acrux

Market Cap: AU$7.3m

Engages in the development and commercialization of generic and topically applied pharmaceutical products in Australia, Europe, the United States, and internationally.

BerGenBio

Market Cap: NOK 48.7m

A clinical-stage biopharmaceutical company, engages in the development of medicines to treat drug resistant, metastatic cancers, and respiratory disease in Norway.

Bone Biologics

Market Cap: US$4.7m

A medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein.

Thunderful Group

Market Cap: SEK 44.7m

Invests, develops, and publishes digital games primarily for PC and console platforms in Sweden.

Lobo EV Technologies

Market Cap: US$4.6m

Engages in the design, development, manufacture, and sales of e-bicycles, e-mopeds, e-tricycles, and electric off-highway four-wheeled shuttles in the People's Republic of China.

Autonomix Medical

Market Cap: US$4.6m

A development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system.

PRO DV

Market Cap: €3.9m

Operates as an IT consulting company in Germany.

4AIM SICAF

Market Cap: €3.9m

A private equity firm specializing in direct, secondary indirect and fund of fund investments.

HeartSciences

Market Cap: US$4.5m

A medical technology company, focuses on applying AI-based technology to an ECG to enhance its clinical utility.

Synergia Energy

Market Cap: UK£3.3m

Engages in the exploration, appraisal, development, production, and sale of oil and gas.

Soligenix

Market Cap: US$4.4m

A late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States.

Argentex Group

Market Cap: UK£3.3m

Engages in the provision of currency risk management and alternative banking solutions in the United Kingdom.

Movano

Market Cap: US$4.4m

A technology company, engages in the development of a platform to deliver healthcare solutions at the intersection of medical and consumer devices.

Revelation Biosciences

Market Cap: US$4.4m

Operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics.

Dermata Therapeutics

Market Cap: US$4.4m

A late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical skin diseases and aesthetic applications.

Theriva Biologics

Market Cap: US$4.3m

A clinical-stage company, develops therapeutics to treat cancer and related diseases in areas of high unmet need in the United States.

Aclarion

Market Cap: US$4.3m

Operates as a healthcare technology company in the United States.

CaliberCos

Market Cap: US$4.3m

A real estate investment, and an asset management firm specializes in middle-market assets.

Virax Biolabs Group

Market Cap: US$4.2m

A biotechnology company, distributes diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of T cell in Vitro Diagnostics.

Alfonsino

Market Cap: €3.5m

Provides online delivery services of food, flowers, groceries, and medicines in municipalities primarily in Italy.

Spruce Biosciences

Market Cap: US$4.0m

A biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders.

Getech Group

Market Cap: UK£3.0m

Engages in locating the subsurface resources essential in United Kingdom, the United States, Australia, rest of Americas, rest of Europe, the United Arab Emirates, Africa, and Asia.

Braille Energy Systems

Market Cap: CA$5.5m

Provides battery manufacturing and energy storage solutions in Canada and internationally.

Eprcomunicazione

Market Cap: €3.4m

Provides strategic consulting and communication services for companies and organizations in Italy.

Flow Beverage

Market Cap: CA$5.4m

Engages in the developing, marketing, selling, and distributing natural alkaline spring water-based beverages under the Flow brand name in Canada and the United States.The company’s spring water available in organic and natural flavours, such as blackberry+hibiscus, strawberry+rose, cucumber+mint, watermelon, grapefruit, cucumber, peach+blueberry, blood orange, meyer lemon, strawberry+kiwi, ginger+lemon, and pomegranate, as well as vitamin-infused water comprising elderberry, citrus, and cherry.

urban-gro

Market Cap: US$3.9m

Engages in the designing, engineering, building, and integrating complex environmental equipment systems for indoor controlled environment agriculture (CEA) cultivation and retail facilities in the United States, Canada, and Europe.

Azitra

Market Cap: US$3.9m

An early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases.

Rapid Nutrition

Market Cap: €3.3m

A natural healthcare company, develops and distributes science-based health and wellness products worldwide.

Windtree Therapeutics

Market Cap: US$3.8m

A biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases.

Xcel Brands

Market Cap: US$3.8m

Operates as a media and consumer products company in the United States.

Ontrak

Market Cap: US$3.8m

Operates as a value-based behavioral healthcare company in the United States.